PavmedPAVM
13F holders, Q2 2024 (June 30)26holders +2
6new positions
4sold out
$0.85avg. 13F price*
At the end of Q2 2024, 26 institutions reported holding Pavmed Inc. (PAVM) in their 13F filings, up 2 from Q1 2024. 6 opened new positions and 4 sold out. The largest holders were First Manhattan Co. Llc. ($408K), Vanguard Group Inc. ($241K) and Axiom Advisory, LLC ($71K).
- Company
- Pavmed Inc.
- CUSIP
- 70387R403
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $107K |
| Exits | 4 | $47K |
All 13F filers, Q1 2024 → Q2 2024: 176,753 shares bought and 33,914 shares sold, net +142,839 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 26 holders
| First Manhattan Co. Llc. | 0.00% | Add +17.6% | 500,000 | $408K |
| Vanguard Group Inc. | 0.00% | Reduce -1.7% | 295,390 | $241K |
| Axiom Advisory, LLC | 0.00% | New | 38,955 | $71K |
| BlackRock Inc. | 0.00% | No change | 74,912 | $61K |
| Geode Capital Management, LLC | 0.00% | Add +16.2% | 73,634 | $60K |
| Two Sigma Securities, LLC | 0.00% | New | 25,225 | $21K |
| State Street Corp. | 0.00% | Reduce -0.6% | 20,854 | $17K |
| Virtu Financial LLC | 0.00% | New | 15,099 | $12K |
| Northern Trust Corp. | 0.00% | Reduce -0.4% | 11,706 | $10K |
| XML Financial, LLC | 0.00% | No change | 10,067 | $8K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +294.9% | 9,704 | $8K |
| Morgan Stanley | 0.00% | Reduce -1.2% | 5,068 | $4K |
| Cwm, LLC | 0.00% | No change | 4,672 | $4K |
| UBS Group AG | 0.00% | New | 4,795 | $4K |
| Wells Fargo & Company | 0.00% | Reduce -45.4% | 3,902 | $3K |
| CIBC Private Wealth Group LLC | 0.00% | No change | 836 | $664 |
| Allworth Financial LP | 0.00% | No change | 420 | $425 |
| Osaic Holdings, Inc. | 0.00% | Reduce -9.4% | 116 | $94 |
| Bank of America Corp. | 0.00% | Add +1028.6% | 79 | $65 |
| Parallel Advisors, LLC | 0.00% | New | 78 | $64 |
| M&R Capital Management Inc. | 0.00% | No change | 67 | $55 |
| JPMorgan Chase & Co. | 0.00% | Add +2.8% | 37 | $30 |
| NewEdge Advisors, LLC | 0.00% | New | 7 | $6 |
| Thompson Investment Management, Inc. | 0.00% | No change | 4 | $3 |
| Steward Partners Investment Advisory, LLC | 0.00% | No change | 1 | $1 |
| Royal Bank of Canada | 0.00% | No change | 11 | $0 |
"% of holder's portfolio" is PAVM's weight in each manager's 13F, not the share of Pavmed Inc. the manager owns.